BILLERICA, Mass.--(BUSINESS WIRE)--Bruker BioSciences Corporation (NASDAQ: BRKR) today reported financial results for the three and six months ended June 30, 2007. For the second quarter of 2007, revenue increased by 21% to $121.7 million, compared to revenue of $100.5 million in the second quarter of 2006. Excluding the effects of foreign currency translation, second quarter 2007 revenue increased by 17% year-over-year. Net income in the second quarter of 2007 was $5.0 million, or $0.05 per diluted share, compared to net income of $2.5 million, or $0.02 per diluted share, in the second quarter of 2006.
